| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |